In last trading session, Calidi Biotherapeutics Inc (AMEX:CLDI) saw 4.48 million shares changing hands with its beta currently measuring 0.90. Company’s recent per share price level of $0.63 trading at $0.06 or 10.52% at ring of the bell on the day assigns it a market valuation of $21.82M. That closing price of CLDI’s stock is at a discount of -517.46% from its 52-week high price of $3.89 and is indicating a premium of 68.25% from its 52-week low price of $0.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 81.02 million shares which gives us an average trading volume of 14.07 million if we extend that period to 3-months.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
Upright in the green during last session for gaining 10.52%, in the last five days CLDI remained trading in the red while hitting it’s week-highest on Thursday, 07/10/25 when the stock touched $0.63 price level, adding 42.73% to its value on the day. Calidi Biotherapeutics Inc’s shares saw a change of -60.06% in year-to-date performance and have moved -9.69% in past 5-day. Calidi Biotherapeutics Inc (AMEX:CLDI) showed a performance of 83.25% in past 30-days. Number of shares sold short was 0.37 million shares which calculate 0.74 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5.5 to the stock, which implies a rise of 88.55% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 9. It follows that stock’s current price would drop -217.46% in reaching the projected high whereas dropping to the targeted low would mean a loss of -217.46% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 84.85% while estimates for its earnings growth in next 5 years are of 53.95%.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
Insiders are in possession of 6.81% of company’s total shares while institution are holding 17.24 percent of that, with stock having share float percentage of 18.50%. Investors also watch the number of corporate investors in a company very closely, which is 17.24% institutions for Calidi Biotherapeutics Inc that are currently holding shares of the company. RED WAVE INVESTMENTS LLC is the top institutional holder at CLDI for having 0.62 million shares of worth $0.12 million. And as of 2024-06-30, it was holding 1.1723 of the company’s outstanding shares.
The second largest institutional holder is CPR INVESTMENTS INC., which was holding about 0.56 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0511 of outstanding shares, having a total worth of $0.11 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 353.38 shares of worth $0.22 million or 0.97% of the total outstanding shares. The later fund manager was in possession of 141.47 shares on May 31, 2025 , making its stake of worth around $89437.0 in the company or a holder of 0.39% of company’s stock.
